A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
Clinical trial NCT04814108 · COMPLETED
Trial details
- NCT number
- NCT04814108
- Sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2025-10-22
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.